iNCOVACC Intra-Nasal Covid Vaccine: Bharat Biotech International Limited announced on Monday (28 November) that Incovacc (iNCOVACC BBV154) has become the world’s first covid vaccine to be administered through the nose (without a needle). In English it is called Intra-Nasal Covid Vaccine. The company said in a press release that the Central Drugs Standard Control Organization (CDSCO) has approved both its dosage forms – primary series and heterologous – for all adults under controlled use in emergency situations. This means that people of 18 years of age or older in India…
Read MoreBharat Biotech INCOVACC Intranasal Covid Vaccine Approved Will Be Used In Such Situation
